课题基金 / 基金详情

PLASMA & ERYTHROCYTE FATTY ACIDS IN TREATED CHILDREN W/ PKU

PLASMA & ERYTHROCYTE FATTY ACIDS IN TREATED CHILDREN W/ PKU
等离子体
批准号:
6415315
负责人:
LOUIS J ELSAS
金额:
$29.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-12-01 至 2001-11-30

项目摘要

项目成果

LOUIS J ELSAS的其他基金

相似基金

相关文献

中文摘要
翻译
本研究旨在验证以下假设:1)服用不同医疗食品的PKU儿童与正常儿童之间的必需脂肪酸摄入量没有差异;2)接受不同医疗食品治疗的PKU儿童与正常儿童之间的血浆和红细胞脂肪酸水平没有差异。研究人员将对正在接受PKU治疗的儿童的全民教育摄入量与他们正常兄弟姐妹的摄入量进行比较。这些儿童服用的是洛芬那酸、苯奈克斯、不含苯丙酚或XP的Maximaid。正在接受PKU治疗的儿童的血浆和红细胞脂肪酸谱将与他们正常兄弟姐妹的脂肪酸谱进行比较,这些儿童正在服用洛芬那酸、苯尼司、不含苯酚或XP的Maxamaid。
英文摘要
This proposal is designed to test the hypotheses that: 1) there are no differences in the intake of essential fatty acids (EFAS) among groups of children with PKU fed different medical foods and normal children, and 2) there are no differences in the plasma and erythrocyte fatty acids among groups of children undergoing therapy for PKU with different medical foods and normal children. The investigators will compare EFA intake of children undergoing therapy for PKU who are ingesting Lofenalac, Phenex, Phenyl-free or XP Maximaid to intakes of their normal siblings. Plasma and erythrocyte fatty acid profiles of children undergoing therapy for PKU who are ingesting Lofenalac, Phenex, Phenyl-free, or XP Maxamaid will be compared to the fatty acid profiles of their normal siblings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMPROVED OUTCOME PREDICTION IN GALACTOSEMIA NEWBORNS
GALACTOSE METABOLIC PATHWAYS
  • 批准号:
    6565726
  • 项目类别:
  • 资助金额:
    $29.31万
  • 财政年份:
    2001
  • 负责人:
    LOUIS J ELSAS
  • 依托单位:
GALACTOSE METABOLIC PATHWAYS--BREATH TEST
  • 批准号:
    6565727
  • 项目类别:
  • 资助金额:
    $29.31万
  • 财政年份:
    2001
  • 负责人:
    LOUIS J ELSAS
  • 依托单位:
PLASMA & ERYTHROCYTE FATTY ACIDS IN TREATED CHILDREN W/ PKU
  • 批准号:
    6586005
  • 项目类别:
  • 资助金额:
    $29.31万
  • 财政年份:
    2001
  • 负责人:
    LOUIS J ELSAS
  • 依托单位:
海外基金